Literature DB >> 8769476

Altered T cell receptor ligands trigger a subset of early T cell signals.

J D Rabinowitz1, C Beeson, C Wülfing, K Tate, P M Allen, M M Davis, H M McConnell.   

Abstract

TCR ligands are complexes of peptides and MHC proteins on the surfaces of APCs. Some of these ligands cause T cell proliferation (agonists), while others block it (antagonists). We compared the acid release, calcium flux, and proliferation response of helper T cells to a variety of ligands. We found that all agonist ligands but not most antagonist ligands trigger acid release, a general indicator of early cellular activation. Only a subset of ligands triggering acid release cause sustained calcium flux, and only a subset of these ligands cause T cell proliferation. Antagonist ligands and anti-CD4 antibodies both effectively block T cell proliferation. However, significantly greater antagonist ligand or antibody concentrations are required to block acid release and initial calcium influx. These data demonstrate a hierarchy of early T cell signaling steps and show that altered TCR ligands can initiate some steps while blocking the completion of others.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8769476     DOI: 10.1016/s1074-7613(00)80489-6

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  53 in total

1.  In vitro evolution of a T cell receptor with high affinity for peptide/MHC.

Authors:  P D Holler; P O Holman; E V Shusta; S O'Herrin; K D Wittrup; D M Kranz
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-09       Impact factor: 11.205

2.  A logical analysis of T cell activation and anergy.

Authors:  M Kaufman; F Andris; O Leo
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-30       Impact factor: 11.205

3.  Homeostatic expansion and phenotypic conversion of naïve T cells in response to self peptide/MHC ligands.

Authors:  W C Kieper; S C Jameson
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-09       Impact factor: 11.205

4.  Functional evidence for TCR-intrinsic specificity for MHCII.

Authors:  Heather L Parrish; Neha R Deshpande; Jelena Vasic; Michael S Kuhns
Journal:  Proc Natl Acad Sci U S A       Date:  2016-02-01       Impact factor: 11.205

Review 5.  Quantitative challenges in understanding ligand discrimination by alphabeta T cells.

Authors:  Ofer Feinerman; Ronald N Germain; Grégoire Altan-Bonnet
Journal:  Mol Immunol       Date:  2007-09-06       Impact factor: 4.407

Review 6.  Recombinant T cell receptor ligands: immunomodulatory, neuroprotective and neuroregenerative effects suggest application as therapy for multiple sclerosis.

Authors:  Halina Offner; Sushmita Sinha; Chunhe Wang; Gregory G Burrows; Arthur A Vandenbark
Journal:  Rev Neurosci       Date:  2008       Impact factor: 4.353

7.  Variant antigenic peptide promotes cytotoxic T lymphocyte adhesion to target cells without cytotoxicity.

Authors:  D M Shotton; A Attaran
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-22       Impact factor: 11.205

Review 8.  To affinity and beyond: harnessing the T cell receptor for cancer immunotherapy.

Authors:  Jessica E Thaxton; Zihai Li
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

Review 9.  Suboptimal engagement of the T-cell receptor by a variety of peptide-MHC ligands triggers T-cell anergy.

Authors:  Scheherazade Sadegh-Nasseri; Sarat K Dalai; Laura C Korb Ferris; Saied Mirshahidi
Journal:  Immunology       Date:  2009-12-02       Impact factor: 7.397

10.  Substitutions in a major histocompatibility complex class II-restricted human immunodeficiency virus type 1 gp120 epitope can affect CD4+ T-helper-cell function.

Authors:  C Lekutis; N L Letvin
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.